PacBio Appoints Haorui Gene as Official Distributor in China
US-based sequencing solutions provider PacBio (NASDAQ: PACB) has appointed China’s Haorui Gene as an official...
Zhongsheng Pharma’s Anruiwei Receives NMPA Approval for Influenza A
China-based Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317) announced that it has received marketing approval...
CARsgen’s Satri-Cel Shows Significant Efficacy in Gastric Cancer Study
China-based CARsgen Therapeutics Holdings Limited (HKG: 2171) announced that it has published an abstract of...
Viz.ai Partners with Sanofi and Regeneron to Deploy AI Solution for COPD
US-based Viz.ai this week announced a multi-year partnership with France-based Sanofi (NASDAQ: SNY) and US-based...
GSK’s Nucala Receives FDA Approval for COPD Treatment
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced that it has received marketing approval from...
Merck’s Welireg Launched in China for Rare Genetic Disorder Treatment
US-based Merck, Sharp & Dohme (MSD; NYSE: MRK) announced the commercial launch of its hypoxia-inducible...
NMPA Approves Bayer/Regeneron’s Eylea HD for Wet AMD Treatment
China’s National Medical Products Administration (NMPA) has approved Bayer (ETR: BAYN) and Regeneron’s (NASDAQ: REGN)...
Ascentage Pharma to Present Data on Lisaftoclax and Alrizomadlin at ASCO 2025
China-based Ascentage Pharma (NASDAQ: AAPG, HKG: 6855) will present the latest data from two ongoing...
Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening
China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with...
Lead Healthcare Raises RMB 100M in Angel Financing to Boost AI-Driven Life Science Instruments
China-based Lead Healthcare Technology (Guangzhou) Co., Ltd reportedly raised close to RMB 100 million (USD...
WinHealth Pharma Expands Long-Term Partnership with Merz Therapeutics
China-based Hong Kong WinHealth Pharma Group this week formally entered into a long-term partnership with...
Servier Acquires BioNova’s BN104 for Acute Leukemia Treatment
French pharmaceutical firm Servier announced a definitive agreement to acquire BN104 from BioNova Pharmaceuticals (Shanghai)...
ImmuneOnco and Instil Bio Announce Clinical Updates for IMM2510 in NSCLC
China-based ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541) and its US partner Instil Bio Inc...
UCB’s Keppra Procurement Resumed in Shanghai After Regulatory Halt
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has issued a notification resuming the procurement of UCB’s...
RemeGen Plans Hong Kong Share Placement to Fund Telitacicept Expansion
China-based biopharma RemeGen Ltd (HKG: 9995) announced plans to place 10.2% of its issued shares...
Ascletis Pharma Starts Phase I Study of ASC50 for Psoriasis in the US
China-based Ascletis Pharma Inc. (HKG: 1672) announced that it has received approval from the US...
Jacobio Pharma’s Glecirasib Approved by NMPA for KRAS G12C+ NSCLC
China-based Jacobio Pharma (HKG: 1167) announced that it has received marketing approval from the National...
AstraZeneca Shuts Down Neuroscience Research Group to Focus on Core Areas
AstraZeneca (AZ; NASDAQ: AZN) confirmed the closure of its neuroscience research group during its 2025...
Hengrui Pharmaceuticals’ Retagliptin and Metformin Approved by NMPA for Type 2 Diabetes
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has announced that it has received marketing...
Roche’s Susvimo Gets FDA Approval for Diabetic Retinopathy
Swiss giant Roche (SWX: ROG, OTCMKTS: RHHBY) announced that its Susvimo (ranibizumab) 100mg/mL intravitreal ocular...